Defafios actuais de Farmacovigilancia

Post published:November 27, 2023

José Alberto Ayala Ortiz, CEO of PVpharm participated in the 1st edition of the Conference organized by OWL Pharma, Desafios Actuais de Farmacovigilancia, held in Lisbon on the 22nd of November 2023. José provided insight about Signal Detection in Pharmacovigilance and the use of EVDAS. Please check OWL Pharma website for more information: https://www.owlpharma.pt/news/o-futuro-de-farmacovigilancia-1a-edicao-desafios-atuais-de-farmacovigilancia **PVpharm is also organizing in-house training in pharmacovigilance for pharmaceutical companies and CROs, please contact us for further information.**

Online XEVMPD training 27-29 November 2023

Post published:November 24, 2023

José Alberto Ayala Ortiz, CEO of PVpharm, will be participating as trainer in the next XEVMPD training on 21-23 February 2024. The training will be delivered online in the morning time (09:00-13:00 CET). The training focuses on explaining the guidance and specifically the mandatory data elements necessary for the electronic submission of information on medicinal products, applying the format of the eXtended EudraVigilance Product Report Message (XEVPRM) and the use of the XEVMPD data entry tool (EVWEB). It includes exercises in the XEVPRM data entry tool (EVWEB) for the electronic submission and maintenance of different types of medicinal products. Please…

Online EVWeb training for SPONSORS 27-29 November 2023

Post published:November 23, 2023

José Ortiz, CEO of PVpharm will be participating as a trainer, in the next EVWeb training specifically targeted for SPONSORs of Clinical trials on 27-29 November 2023. The training will be delivered online in the morning time (9:00-13:00 CET). The training is targeted to: -Sponsors who have to report and analyse suspected adverse reactions in the pre- authorisation phase using the ISO/ICH E2B(R3) ICSR format-Users of EudraVigilance – new users and users already trained on working with EudraVigilance-Professionals performing electronic transmission of ICSRs, who operate as Gateway traders or as WebTrader (i.e., who use EVWEB or EV Post)-Sponsors of Clinical…

José Alberto Ayala Ortiz to participate as speaker in the AEFI Pharmacovigilance in Social Networks Training

Post published:November 2, 2023

We are happy to announce that José Alberto Ayala Ortiz, PVpharm's CEO will be participating as speaker in the AEFI Pharmacovigilance in Social Networks Training. The training will take place on Monday 6th November from 16:00 to 19:00, please find more information about the training in the link below: https://aefi.org/eventos/farmacovigilancia-en-la-era-digital/?mc_cid=ddb97c2046&mc_eid=54a2a50032 During the session, José will be talking about several topics related to Pharmacovigilance and handling of safety related information detected in Social Networks.